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Backgroun& Surgery for portal hypertension has a
low rebleeding rate. Patients that rebleed can be
grossly divided into those who die as a consequence
of the episode, those who don’t die but develop liver
failure (remaining as Child-Pugh C) and those who,
in spite of the bleeding episode, retain good liver
function (Child-Pugh A or B). At our hospital, the
latter group is considered for further surgical
treatment. We report here the results of surgical
rescue of surgical failures.
Methods; In a twenty year period, 36 patients (30
Child-Pugh A, 6 Child-Pugh B) were reoperated. The
files of these patients were reviewed.
Results; Average age was 33 years. Cirrhosis was
present in 31 cases. All patients were electively
reoperated with portal blood flow preserving pro-
cedures. Operative mortality for the whole group
was 12% and for the Child-Pugh A group 6.6%. Re-
bleeding was observed in 5.5%. Postoperative
incapacitating encephalopathy was recorded in one
case (2.7%). Good quality of life was recorded in 84%
of the cases. Survival (Kaplan-Meier) was 78% at 6
months and 69% at 5 years.
Conclusions; Surgical failures in low risk patients
(Child-Pugh A or B) can be treated by means of
surgery, and a low mortality, re-bleeding and
encephalopathy rate can be expected. The perfor-
mance of a portal blood flow preserving procedure
is recommended.
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The most effective treatment for hemorrhagic
portal hypertension (HPH) is surgery. It has the
lowest re-bleeding rate among the different
treatment alternatives. The types of procedures
and their indications have evolved in the last
decade [1]. It has been demonstrated that the
main indication for surgery is in patients with a
history of bleeding and good liver function (low
risk patients) and these patients should be
operated on in an elective fashion [2]. Portal
blood flow preserving procedures (selective
shunts, Sugiura-Futagawa procedure, low dia-
meter shunts) are the preferred operation for
most patients. In many centers, a low operative
mortality as well as a low re-bleeding and
encephalopathy rate has been achieved. There
is no doubt that for low risk patients, portal
blood flow preserving procedures are the treat-
ment of choice [3].
Re-bleeding rates after surgery are usually
below 10% [4-7]. Patients who rebled can be
grossly divided into those who die as a
consequence of the episode, those who develop
liver failure and those who spite of the bleeding
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episode, recover and remain with good liver
function (Child-Pugh A or B).
Many centers manage surgical failures with
other forms of therapy which include sclerother-
apy, intrahepatic shunts (TIPS) and in some
instances with liver transplants. Sclerotherapy
has a high re-bleeding rate (30% to 50%) while
TIPS have a high rate of dysfunction. Liver
transplants are reserved for those patients with
bad liver function.
Here, we report our results with the surgical
management of previously operated HPH pa-
tients with good liver function, that is, the
surgical rescue of surgical failures.
characteristics of the splenomesenteric portal
system, patients are selected to receive a selec-
tive shunt (distal splenorenal or splenocaval), a
Sugiura-Futagawa operation, or a low diameter
(mesocaval) shunt. After the operation, routine
follow-up is performed and in the cases with a
shunt operation, angiograms are done to evalu-
ate the shunt patency.
The files of the patients reoperated on for re-
bleeding were reviewed. Demographic data of
the patients were recorded as well as the results
of the reoperation. Early and late mortality,
postoperative encephalopathy, re-bleeding, sur-
vival and quality of life were studied [8].
METHODS RESULTS
In the last two decades, surgical treatment of
portal hypertension has been standardized in
our hospital. No prophylactic cases are operated.
Only patients with a good liver function are
electively operated using portal blood flow
preserving procedures. These are the selective
shunts, the Sugiura-Futagawa operation and in
the last 5 years, also low diameter shunts [3].
The patients selected for surgery must fulfill
the following criteria [5]:
(a) History of bleeding secondary to portal
hypertension.
(b) Good cardiopulmonary and renal function
(c) Good liver function
Albumin > 3.5 gr/dl
Total bilirubin < 2mg/dl
Prothrombin time < 2 seconds
No encephalopathy
No ascitis
(d) Good nutritional status
All patients selected for surgery, including
those with a history of surgery, are subjected to
an angiographic evaluation of the arterial and
venous phases of the celiac trunk and mesenteric
artery. According to the anatomical findings and
In a 20 year period, among 667 patients operated
for bleeding portal hypertension, 36 were found
to have a reoperation. Patients that had bleeding
from other sources (not related to portal hyper-
tension) were excluded. There were 23 male and
13 female patients. Age average was 33 years
(range 14 to 66 years). In 31 cases, hepatic
cirrhosis was demonstrated. Two had congenital
hepatic fibrosis an three portal vein thrombosis.
All patients had a liver biopsy at the operation.
According to the Child-Pugh classification, 30
patients were classified as A (71%) and six (14%)
as Child-Pugh B. All patients were electively
reoperated and four patients died in the first 30
postoperative days and recorded as operative
mortality (12%). According to the Child Pugh
classification, 2 cases corresponded to the group
A (6.6%) (Tab. I). At the time of review, 23
patients were alive and well. Seven late mor-
talities were recorded and two cases were lost to
follow up. The main cause of death was liver
failure.
In Table II, the information about the failure
and cause of rebleeding and the kind of the
reoperation is given. Thirty cases were failures
from our hospital and six cases came from other
hospitals. In all instances, the reoperationsREOPERATIONS FOR BLEEDING PORTAL HYPERTENSION 153
TABLE Mortality
Early (0-30 days) Late (> 30 days)
Child Cause Child Cause Time
A Liver failure
A Multiorganic failure
B Liver failure
B Multiorganic failure
A HIV infection 45 months
A Liver failure 3
A Liver failure 6
B Re-bleeding 7
A Liver failure 52
B Liver failure 2
A Re-bleeding 4
Previous operation
TABLE II Previous operations and reoperations
Rebleeding Reoperation
Devascularization 12
Sugiura-Futagawa 9
Complete 6
Abdominal 3
Selective shunt 12"
DSRS 5
Splenocaval 6
Coronario caval
Total shunts 2*
Mesocaval 1
Portocaval
Esophagogastric
Varices 8
Gastric Varices 4
Gastropathy 0
Esophagogastric
Varices 3
Gastric Varices
(Fundic) 4
Gastropathy 2
Esophagogastric
Varices 12
Esophagogastric
Varices 2
Sugiura-Futagawa 10
Selective shunt
Mesocaval
Low diameter mesocaval shunt 8
Thoracic stage of SF 1"*
Sugiura-Futagawa 6
Selective shunt 3**
Devascularizations
Mesocaval
Sugiura-Futagawa 2
Obstructed shunts.
A DSRS was converted to splenocaval shunt. Two splenocaval were converted to a DSRS.
performed were portal blood flow preserving
procedures. Operative interval was between 1
and 5 years for 9 patients, between 5 and 10
years for 9 patients and more than 10 years for
five patients.
Re-bleeding was recorded in two of the 36
cases (5.5%) with a mean follow up to 60
months. The two patients died in the 4th and
7th postoperative months. Postoperative ence-
phalopathy was recorded in one case (2.7%)
after reoperation. This patient had history of
Sugiura-Futagawa operation that failed in the
first year and a low diameter mesocaval shunt
(10mm ringed PTFE) was done. According to
our criteria [8] for evaluation of quality of life, it
was good for 84% of the cases and bad for 16%
of cases. Survival (Kaplan-Meier) was 78% at 6
months and 69% at 5 years. (Fig. 1).
DISCUSSION
Among the alternatives to control variceal
bleeding, surgery remains as the most effective
treatment. Re-bleeding rate is low in most series.
Portal blood flow preserving procedures are the
preferred operations [3]. In almost all centers in
which surgery is routinely performed for the
treatment of bleeding portal hypertension, selec-
tion of cases has been over emphasized. If
surgery is electively performed in low risk
patients (Child-Pugh A), good results are to be
expected. Most of these patients do well after the
operation, with a good quality of life [8].
Nevertheless, surgery has failures and there is
virtually no series in which re-bleeding is not
reported. For shunt surgery, the most likely
cause of re-bleeding is shunt dysfunction.154 M.A. MERCADO et al.
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FIGURE Survival curve for our series of 36 patients.
Selective shunts have a very low rate of
obstruction and/or dysfunction [9,10], less than
5% in our experience. For devascularizations,
the cause is more difficult to explain, but
certainly in spite of interrupting afferent and
afferent vessels, portal hypertension still re-
mains in the esophagogastric area, and variceal
recurrence may occur. This event is less frequent
in our experience for the extensive Sugiura-
Futagawa devascularization.
Patients that fail to surgery have the possibi-
lity of rebleeding from other sources. This paper
discusses only the patients that had rebleeding
because of portal hypertension.
For patients with obstructed shunts esopha-
gogastric varices is the most common site of
rebleeding. This is particularly true for the
DSRS, in which the whole esophagogastric and
splenic area is drained through the shunt. For
patients with devascularization procedures, gas-
tric varices and hypertensive gastropathy repre-
sent a considerable source of bleeding.
In some cases, re-bleeding has a fatal outcome.
In other cases, liver function deteriorates after
re-bleeding. In another subset of patients, no
changes in liver function are observed and they
remain as Child-Pugh A. There is no agreement
on how to treat these patients. In many centers,
surgical failures are treated with alternate
therapeutic choices, including sclerotherapy,
TIPS and liver transplantation. Sclerotherapy
has a high re-bleeding rate and in our opinion
should be reserved for patients with bad liver
function [2]. Liver transplantation is not indi-
cated as treatment for re-bleeding, but there is
no doubt that for patients with bad liver
function, it is the treatment of choice [12], and
TIPS are indicated as "a bridge" for liver
transplantation and its role for long term
treatment has not established yet. The high rate
of dysfunction (as well as the fact that it is a non
portal blood flow preserving procedure) does
not make TIPS the treatment of choice for
patients with good liver function [13].
The results reported here support the surgical
rescue for surgical failures, for those patiehts
with good liver function. Although reoperations
are technically more difficult because of adhe-
sions due to the previous procedure which
makes intraoperative blood loss significantly
higher. The operative mortality is low for
patients with good liver function (less thanREOPERATIONS FOR BLEEDING PORTAL HYPERTENSION 155
10% for Child .A cases). Results are similar for
the low risk patients operated for the first time.
There is a low re-bleeding rate after the opera-
tion (less than 5%) and if a portal blood flow
preserving procedure is done, a low encephalo-
pathy rate is obtained.
The kind of procedure to be done depends on
many variables. Some of these patients have no
spleen or have an inadequate splenic vein. So, if
it is not possible to do a selective shunt, these
patients should be considered for a Sugiura-
Futagawa procedure or a low diameter shunt (if
the portal and mesenteric veins are adequate).
Our preference for the cases in which a
selective shunt is not possible is to perform a
Sugiura-Futagawa operation. Our results with
low diameter shunts, although encouraging, are
not as good a those obtained with the selective
shunts and the Sugiura-Futagawa procedure. So,
we reserve low diameter shunts for the cases in
which a selective shunt or the Sugiura-Futagawa
procedure is not possible, for example, a patient
with history of esophagogastric devasculariza-
tion and absence of spleen or inadequate spleen
vein.
In some cases with a history of devasculariza-
tion and an inadequate spleno meso portal
system, a Sugiura-Futagawa operation has to
be done. For these cases with a history of
abdominal devascularization, a trans thoracic
approach to perform the devascularization and
esophageal transection has to be done.
It is concluded that surgical failures have to be
treated by means of surgery, if the patient has
good liver function after re-bleeding and can be
electively operated. We strongly recommend the
performance of a portal blood flow preserving
procedures. We advice that shunt failures
should be treated with the Sugiura-Futagawa
operation, considering low diameter shunts as
another alternative. Failure of devasculariza-
tions can be treated with shunts and in certain
selected circumstances (no adequate vessels)
devascularizations have to be converted to the
Sugiura-Futagawa operation.
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